TABLE 1 CONTRACEPTIVE MARKET REVENUE BY TYPE' 2016-2023 ($BILLION) 35
TABLE 2 GLOBAL CONTRACEPTIVES MARKET REVENUE BY REGIONS FORECAST' 2016-2023 ($MILLION) 46
TABLE 3 DRO (NORTH AMERICA) 47
TABLE 4 DRO (EUROPE) 48
TABLE 5 DRO (APAC) 50
TABLE 6 DRO (REST OF THE WORLD) 51
TABLE 1 ALLERGAN PLC: PRODUCT OFFERINGS 55
TABLE 2 ALLERGAN PLC: RECENT DEVELOPMENTS 55
TABLE 3 BAYER AG: PRODUCT OFFERINGS 61
TABLE 4 BAYER AG: RECENT DEVELOPMENTS 61
TABLE 5 CHURCH & DWIGHT CO.' INC.: PRODUCT OFFERINGS 65
TABLE 6 CHURCH & DWIGHT CO.' INC.: RECENT DEVELOPMENTS 65
TABLE 7 MERCK & CO: PRODUCT OFFERINGS 69
TABLE 8 MERCK & CO: RECENT DEVELOPMENTS 70
TABLE 9 TEVA PHARMACEUTICAL INDUSTRIES LTD: PRODUCT OFFERINGS 74
TABLE 10 TEVA PHARMACEUTICAL INDUSTRIES LTD: RECENT DEVELOPMENTS 74

LIST OF FIGURE

Charts

CHART 1 CONTRACEPTIVE PREVALENCE AMONG MARRIED OR IN-UNION WOMEN AGED 15 TO 49 YEARS 10
CHART 2 PERCENTAGE OF ADOLESCENCE WOMEN AT EACH AGE GROUP IN ALL DEVELOPING REGIONS 2016 10
CHART 3 PERCENTAGE SPLIT OF 252 MILLION WOMEN AGED 15-19 YEARS' 2016 11
CHART 4 PERCENTAGE OF MODERN CONTRACEPTION METHODS USAGE AMONG WOMEN AGED 15 TO 49 YEARS (MARRIED OR IN A UNION)' 2015 12
CHART 5 NUMBER OF MARRIED OR IN UNION WOMEN USING CONTRACEPTION (MILLIONS)' IN 2015 13
CHART 6 DEVELOPMENTS IN CONTRACEPTIVE METHODS 13
CHART 8 RESEARCH METHODOLOGY 17
CHART 9 GLOBAL MEDICAL INDUSTRY SEGMENTATION 19
CHART 10 MEDICAL ELIGIBILITY BY CATEGORIES 21
CHART 11 GLOBAL CONTRACEPTIVES MARKET REVENUE' 2016-2023 ($MILLION) 22
CHART 12 PORTERS 5 FORCES ON CONTRACEPTIVES MARKET 22
CHART 13 CONTRACEPTIVES MARKET SEGMENTATION 23
CHART 14 MARKET DYNAMICS - DRIVERS' RESTRAINTS' AND OPPORTUNITIES 25
CHART 15 GLOBAL CONTRACEPTIVE PREVALENCE AMONG MARRIED OR IN-UNION WOMEN AGED 15 TO 49 YEARS' 2015 26
CHART 16 THE PERCENTAGE OF THOSE WHO LIMIT BIRTH IS TWICE AS HIGH IN SOUTH CENTRAL ASIA AND SOUTHEAST ASIA WHEN COMPARED TO THOSE WOMEN IN SUB-SAHARAN AFRICA. 27
CHART 17 DRO - IMPACT ANALYSIS OF IOT HEALTHCARE MARKET 32
CHART 18 KEY STAKEHOLDERS 33
CHART 19 CONTRACEPTIVES MARKET SEGMENTATION BY PRODUCT TYPE' 2016 33
CHART 20 CONTRACEPTIVES MARKET REVENUE BY TYPE' 2016-2023 ($MILLION) 34
CHART 21 PERCENTAGE SPLIT OF CONTRACEPTIVE MARKET 2016 35
CHART 22 CONTRACEPTIVE DRUGS MARKET SEGMENTATION 2016 36
CHART 23 CONTRACEPTIVES DRUGS MARKET REVENUE' 2016-2023 37
CHART 24 CONTRACEPTIVE DEVICES MARKET REVENUE' 2016-2023 ($MILLION) 38
CHART 25 CONTACEPTIVE DEVICES MARKET SEGMENTATTION 2016 38
CHART 26 CONTRACEPTIVE DEVICES SEGMENTATION 2016 (% SHARE) 39
CHART 27 GLOBAL CONDOM MARKET REVENUE' 2016-2023 ($MILLION) 40
CHART 28 GLOBAL IUD MARKET REVENUE' 2016-2023 ($MILLION) 40
CHART 29 GLOBAL SUB-DERMAL IMPLANTS MARKET REVENUE' 2016-2023 ($MILLION) 41
CHART 30 GLOBAL VAGINAL RINGS MARKET REVENUE' 2016-2023 ($MILLION) 42
CHART 31 GLOBAL NON-SURGICAL PERMANENT CONTRACEPTIVE MARKET REVENUE' 2016-2023 ($MILLION) 42
CHART 32 GLOBAL DIAPHRAGMS MARKET REVENUE' 2016-2023 ($MILLION) 43
CHART 33 GLOBAL SPONGES MARKET REVENUE' 2016-2023 ($MILLION) 44
CHART 34 GLOBAL CONTRACEPTIVES MARKET BY GEOGRAPHICAL SEGMENTATION' 2016 AND 2023 (% SHARE) 45
CHART 35 GLOBAL CONTRACEPTIVES MARKET OVERVIEW BY REGIONS 2016 ($ MILLION) 45
CHART 36 CONTRACEPTIVES MARKET REVENUE IN NORTH AMERICA' 2016-2023 ($MILLION) 46
CHART 37 CONTRACEPTIVES MARKET REVENUE IN THE EUROPE' 2016-2023 ($MILLION) 48
CHART 38 CONTRACEPTIVES MARKET REVENUE IN APAC' 2016-2023 ($MILLION) 49
CHART 39 CONTRACEPTIVES MARKET REVENUE IN THE REST OF THE WORLD' 2016-2023 ($MILLION) 51
CHART 40 GLOBAL CONTRACEPTIVES MARKET SEGMENTATION BY GEOGRAPHY' 2016-2023 ($MILLION) 52
CHART 41 GLOBAL CONTRACEPTIVES MARKET SEGMENTATION BY GEOGRAPHY' 2016-2023 (% SHARE) 52
CHART 42 ALLERGAN PLC: OVERVIEW SNAPSHOT 57
CHART 43 ALLERGAN PLC: BUSINESS UNITS 58
CHART 44 ALLERGAN PLC: SWOT ANALYSIS 59
CHART 45 BAYER AG: OVERVIEW SNAPSHOT 62
CHART 46 BAYER AG: BUSINESS UNITS 63
CHART 47 BAYER AG: SWOT ANALYSIS 64
CHART 48 CHURCH & DWIGHT CO.' INC.: OVERVIEW SNAPSHOT 66
CHART 49 CHURCH & DWIGHT CO.' INC.: BUSINESS UNITS 67
CHART 50 CHURCH & DWIGHT CO.' INC.: SWOT ANALYSIS 68
CHART 51 MERCK & CO: OVERVIEW SNAPSHOT 70
CHART 52 MERCK & CO: BUSINESS UNITS 71
CHART 53 MERCK & CO: SWOT ANALYSIS 72
CHART 54 TEVA PHARMACEUTICAL INDUSTRIES LTD: OVERVIEW SNAPSHOT 74
CHART 55 TEVA PHARMACEUTICAL INDUSTRIES LTD: BUSINESS UNITS 76
CHART 56 TEVA PHARMACEUTICAL INDUSTRIES LTD: SWOT ANALYSIS 77